Norris JD - Search Results

1

Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy.

Wardell SE, Yllanes AP, Chao CA, Bae Y, Andreano KJ, Desautels TK, Heetderks KA, Blitzer JT, Norris JD, McDonnell DP. Wardell SE, et al. Among authors: norris jd. Breast Cancer Res Treat. 2020 Feb;179(3):769. doi: 10.1007/s10549-019-05498-0. Breast Cancer Res Treat. 2020. PMID: 31734822 Free PMC article.

2

Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers.

Norris J, Fan D, Aleman C, Marks JR, Futreal PA, Wiseman RW, Iglehart JD, Deininger PL, McDonnell DP. Norris J, et al. J Biol Chem. 1995 Sep 29;270(39):22777-82. doi: 10.1074/jbc.270.39.22777. J Biol Chem. 1995. PMID: 7559405 Free article.

3

BRCA1 expression is not directly responsive to estrogen.

Marks JR, Huper G, Vaughn JP, Davis PL, Norris J, McDonnell DP, Wiseman RW, Futreal PA, Iglehart JD. Marks JR, et al. Among authors: norris j. Oncogene. 1997 Jan 9;14(1):115-21. doi: 10.1038/sj.onc.1200808. Oncogene. 1997. PMID: 9010238

4

Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.

Ramamoorthy K, Wang F, Chen IC, Norris JD, McDonnell DP, Leonard LS, Gaido KW, Bocchinfuso WP, Korach KS, Safe S. Ramamoorthy K, et al. Among authors: norris jd. Endocrinology. 1997 Apr;138(4):1520-7. doi: 10.1210/endo.138.4.5056. Endocrinology. 1997. PMID: 9075711

5

Identification of a third autonomous activation domain within the human estrogen receptor.

Norris JD, Fan D, Kerner SA, McDonnell DP. Norris JD, et al. Mol Endocrinol. 1997 Jun;11(6):747-54. doi: 10.1210/mend.11.6.0008. Mol Endocrinol. 1997. PMID: 9171238

6

Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone.

McDonnell DP, Norris JD. McDonnell DP, et al. Among authors: norris jd. Osteoporos Int. 1997;7 Suppl 1:S29-34. doi: 10.1007/BF01674810. Osteoporos Int. 1997. PMID: 9205643 Review. No abstract available.

7

The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.

Wagner BL, Norris JD, Knotts TA, Weigel NL, McDonnell DP. Wagner BL, et al. Among authors: norris jd. Mol Cell Biol. 1998 Mar;18(3):1369-78. doi: 10.1128/MCB.18.3.1369. Mol Cell Biol. 1998. PMID: 9488452 Free PMC article.

8

Enhancement of estrogen receptor transcriptional activity by the coactivator GRIP-1 highlights the role of activation function 2 in determining estrogen receptor pharmacology.

Norris JD, Fan D, Stallcup MR, McDonnell DP. Norris JD, et al. J Biol Chem. 1998 Mar 20;273(12):6679-88. doi: 10.1074/jbc.273.12.6679. J Biol Chem. 1998. PMID: 9506965 Free article.

9

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

Paige LA, Christensen DJ, Grøn H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM. Paige LA, et al. Among authors: norris jd. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3999-4004. doi: 10.1073/pnas.96.7.3999. Proc Natl Acad Sci U S A. 1999. PMID: 10097152 Free PMC article.

10

Peptide antagonists of the human estrogen receptor.

Norris JD, Paige LA, Christensen DJ, Chang CY, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP. Norris JD, et al. Science. 1999 Jul 30;285(5428):744-6. doi: 10.1126/science.285.5428.744. Science. 1999. PMID: 10426998

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page